4.1 Article

Novel pyrazolo[1,5-a]pyridines as PI3K inhibitors: variation of the central linker group

期刊

MEDCHEMCOMM
卷 5, 期 1, 页码 41-46

出版社

ROYAL SOC CHEMISTRY
DOI: 10.1039/c3md00221g

关键词

-

资金

  1. Health Research Council of New Zealand
  2. Maurice Wilkins Centre for Molecular Biodiscovery
  3. Pathway Therapeutics

向作者/读者索取更多资源

As part of our investigation into the pyrazolo[1,5-a] pyridines as novel PI3K inhibitors, we report a range of analogues where the central linker portion of the molecule was varied while retaining the pyrazolo[1,5-a] pyridine and arylsulfonyl or arylcarbonyl groups. Isostere generating software BROOD was used to assist with producing ideas. The isoform selectivity of the compounds varied from pan-PI3K for compound 41 to p110 alpha-selective for compound 58 or p110 delta-selective for compound 57. The latter two compounds varied only in their sulphur oxidation state.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据